Sigma-Aldrich Corp (SIAL) 97.27 $SIAL
Sigma-Aldrich Earnings In Retrospect: Up 2.2% in the Last 18 Days (SIAL)
Comtex SmarTrend(R) - Mon May 12, 11:19AM CDT
18 days ago, on April 24th, 2014, Sigma-Aldrich (NASDAQ:SIAL) reported its earnings. Analysts, on average, expected earnings of $1.03 per share on sales of $690.0 million. Sigma-Aldrich actually reported earnings of $1.06 per share on sales of $689.0 million, beating EPS estimates by $0.03 and missing revenue estimates by $1.0 million. Since the company's report, shares of Sigma-Aldrich have risen from $94.76 to $96.84, representing a gain of 2.2% in the past 18 days.
Global Transfection Technology (Reagent-based method, Instrument-based method and Virus-based method) Market - Forecast to 2019
M2 - Fri May 09, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h75tdm/transfection) has announced the addition of the "Transfection Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Transfection is a process that involves production of genetically modified cells with the delivery of foreign nucleic acid (DNA or RNA) into the cell. There are two types of transfection technologies that include stable and transient. While stable transfection is permanent and the genes are continually expressed even after the host cell replicates, transient transfected genes are expressed for a limited period of time and are not integrated into the host genome. Increasing prevalence of cancer and growing obese population drives the global transfection technology market. In addition, initiatives taken by various government organizations also further accentuates the growth of this market. Transfection technologymarket is segmented mainly by types of method and application. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method. The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, cationic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Reagent based transfection technology market is experiencing significant growth owing to cost effectiveness and less complicated methods involved during transfection. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.Instrument-based methods are less time consuming and accurate;these advantages drive the growth of this segment. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Transfection Technology Market, by Methods Chapter 5 Global Transfection Technology Market, By Application Chapter 6 Global Transfection Technology Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Bio-Rad Laboratories, Inc. - Harvard Bioscience, Inc. - Life Technologies Corporation - Lonza Group Ltd. - Merck KGaA - Mirus Bio LLC - Polyplus-transfection S.A. - Promega Corporation - QIAGEN - Roche Holding AG - Sigma-Aldrich Corporation - SignaGen Laboratories - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/h7...ansfection
Global Protein Expression Market, 2018: Products, Application & Expression Systems Opportunities
M2 - Wed May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/62kkkn/protein) has announced the addition of the "Global Protein Expression Market, 2018: Products, Application & Expression Systems Opportunities " report to their offering. The report provides a granular understanding of the global protein expression market. It segments the global market by expression systems, products, applications, and end users. Insect, mammalian, prokaryotic, yeast, and others are the expression system segments of the market. The prokaryotic expression system segment commanded the largest share of the global market in 2013. The mammalian cell expression system segment is poised to grow at the highest CAGR between 2013 and 2018, owing to the increase in demand of therapeutic proteins with appropriate post-translational modifications. The product segments of the global market included in this report are competent cells, expression vectors, instruments, reagents, and services. The reagents segment commanded the largest share of the global market, while the services segment is poised to grow at the highest CAGR between 2013 and 2018 on account of the rising trend of services that provide custom optimization of protein expression for emerging research labs and companies who lack resources and expertise. The applications segment of the global protein expression market comprises of industrial proteins, research applications, and therapeutic proteins. Of these, the therapeutic proteins segment commanded the largest share of the global market in 2013. It is also poised to grow at the highest CAGR between 2013 and 2018, owing to the versatile advantages of therapeutic proteins over small molecule drugs to alleviate diseases. The end-user segments of the global protein expression market included in this report are academic research, contract research organizations, pharmaceutical and biotechnological companies, and others. The pharmaceutical and biotechnological companies segment commanded the largest share of the global market, while the contract research organizations segment is poised to grow at the highest CAGR between 2013 and 2018 due to the growing trends of outsourcing by pharmaceutical and biotechnological companies. Scope Products - Expression Vector - Service - Reagent Application - Industrial - Therapeutic Expression Systems - Mammalian - Prokaryotic - Baculovirus - Yeast End User - Pharmaceutical - Biotechnology - CRO Companies Mentioned - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Life Technologies Corporation - Merck Millipore - New England Biolabs, Inc. - Promega Corporation - Qiagen - Sigma-Aldrich Corporation - Takara Bio, Inc. - Thermo Fischer Scientific Inc. For more information visit http://www.researchandmarkets.com/research/62kkkn/protein
SAFC's Pharmorphix® Technologies and BioTools Align to Provide End-to-End Chiral Technology Tools and Services
PR Newswire - Wed May 07, 6:00AM CDT
Sigma-Aldrich® Corporation's (NASDAQ: SIAL) custom manufacturing and services business unit, SAFC Commercial (www.sigma-aldrich.com/safc), has entered into a collaborative technology agreement with BioTools Inc. (www.btools.com). The partnership aligns BioTools, a Jupiter, Fla.-based manufacturer of advanced chiroptical spectroscopic instruments, with SAFC's leading solid-state research and development business, Pharmorphix®. The combined offer provides customers direct access to the most comprehensive range of chiral structural determination tools and separation services in the market, potentially accelerating timelines to market for chiral-based drugs.
Sigma-Aldrich Corporation Declares Quarterly Dividend
PR Newswire - Tue May 06, 4:00PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company (the "Company"
, announces a quarterly cash dividend of $0.23 per common share. The dividend was approved by the Company's Board of Directors on May 6, 2014 and is payable on June 13, 2014 to shareholders of record at the close of business on May 30, 2014.
Sigma-Aldrich Launches High-Fidelity CRISPRs to Enable Precise Gene Editing for Academic and Industrial Applications
PR Newswire - Tue May 06, 6:00AM CDT
Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the availability of high-fidelity Sigma® CRISPR paired nickases, a novel patent-pending gene editing tool that can be easily and inexpensively employed in academic, agricultural, pharmaceutical, human health and other applications. The high-fidelity CRISPR technology has been designed to reduce unintended off-target gene modifications, providing the research community with a robust, reliable and precise tool to interrogate and modify plant, animal, and human biology.
Reported and Upcoming Financial Results, and Dividends - Analyst Notes on Cloud Peak Energy, Rockwood, Denbury, Sigma-Aldrich and Alliance Resource Partners
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cloud Peak Energy Inc. (NYSE: CLD), Rockwood Holdings, Inc. (NYSE: ROC), Denbury Resources Inc. (NYSE: DNR), Sigma-Aldrich Corporation (NASDAQ: SIAL) and Alliance Resource Partners, L.P. (NASDAQ: ARLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1950-100free.
Sigma-Aldrich Corporation Announces Webcasts Of Annual Shareholders Meeting And Participation At Investor Conferences
PR Newswire - Thu May 01, 3:05PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), will hold its 2014 Annual Shareholders Meeting on Tuesday, May 6, 2014 at 11:00 AM Central Time at the Sigma-Aldrich Corporation Life Science and Technology Center located at 2909 Laclede Avenue, St. Louis, MO. Presenters will include: President and CEO, Rakesh Sachdev; and Executive Vice-President and CFO, Jan Bertsch. The Annual Meeting Rules of Conduct are available at http://investor.sigmaaldrich.com/ under "Corporate Governance."
Sigma-Aldrich® Named to CR Magazine's 100 Best Corporate Citizens List
PR Newswire - Wed Apr 30, 6:00AM CDT
Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named by Corporate Responsibility (CR) Magazine to its list of the 100 Best Corporate Citizens, which ranks public companies based on outstanding corporate responsibility performance in 2013. Sigma-Aldrich ranked 28 on the list in its third appearance.
Global Cell Analysis Market 2014-2019: Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR) & Application (Cell ID, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell)
M2 - Mon Apr 28, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8bcf6h/cell_analysis) has announced the addition of the "Global Cell Analysis Market 2014-2019: Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables & Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis)" report to their offering. In the recent years, the adoption of Cell Analysis for Cell identification, single cell analysis, cell proliferation, cell signaling, cell viability, cell signaling/transduction pathway, cell counting and quality control, cell structure study, and cell interaction, has increased. The market is broadly classified based on products, applications, end users, and geographies. The products market is further divided into instruments and consumables. The instruments market is sub-divided into cell counting instruments, microscopy, flow cytometry, high content screening, spectrophotometery, microfluidics, qRT-PCR, and cell microarrays. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The applications market includes cell identification, cell interaction, cell viability, cell proliferation, cell structure studies, cell signaling pathway/signal transduction, cell counting and quality control, target identification, and validation and single cell analysis. Cell identification has its application in the identification of blood cells on the basis of their size and other morphological features such as presence or absence of nucleus in the cell and shape of nucleus. Cell identification is also used in tumor cell identification with the help of Raman spectroscopy and microfluidics. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. HCS can also provide more accurate information about drug toxicity and mode of actions, which helps in further decision making and in driving the progress of drug discovery. Cell signalling pathways are used for the analysis of signalling pathways in drug discovery and therapeutic development, to differentiate drug resistant patterns in cancerous cells. The major factors driving the growth of the market are the rising incidence of cancer, corporate and government funding for cell-based research activities, rising incidence of chronic and infectious diseases, introduction of enhanced informatics solutions and improvements in image analysis products, and growing healthcare and medical spending. Moreover, the adoption of cell analysis for cell identification and cell signaling pathways/signal transduction pathways is the key growth opportunity in this market. Scope Instruments - Flow Cytometer - Microscope - Microfluidics - QPCR Consumables Application - Cell Identification - Cell Viability - Cell Proliferation - Cytology - Signal Transduction - Single Cell Analysis The report provides insights on the following pointers: - Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the cell analysis market. The report analyzes the cell analysis market by application across geographies. - Product Development/Innovation: Detailed insights on research and development activities and new product launches in the cell analysis market. - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the cell analysis market by product across geographies. - Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market. - Competitive Assessment: In-depth assessment of strategies, products and services, and distribution networks in the cell analysis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Analysis Market, By Product Type 5 Products Market 6 Global Cell Analysis Market, By End Users 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - Agilent Technologies, Inc. - Beckton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corpopration - Perkinelmer, Inc. - Promega Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8b...l_analysis
Sigma-Aldrich Q1 Earnings Top, Backs View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 11:49AM CDT
Sigma-Aldrich's (SIAL) first-quarter earnings topped the Zacks Consensus Estimate but sales miss.
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted EPS Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted EPS Guidance Of $4.30 To $4.40.
PR Newswire - Thu Apr 24, 7:00AM CDT
HIGHLIGHTS:
Earnings Release Schedule -- Research on Coca-Cola Enterprises, Alexion Pharma, DuPont Fabros Technology, and Sigma-Aldrich
PR Newswire - Wed Apr 23, 10:03AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Coca-Cola Enterprises Inc. (NYSE: CCE), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), DuPont Fabros Technology Inc. (NYSE: DFT) and Sigma-Aldrich Corp. (NASDAQ: SIAL). Full earnings notes on CCE, ALXN, DFT and SIAL can be downloaded upon signing up at:
Chelating Agents Market Report 2013-2019: APCA, Sodium Gluconate, Organophosphates and Others
M2 - Tue Apr 22, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bq6tmq/chelating_agents) has announced the addition of the "Chelating Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Chelating agents are organic molecules, which have the ability to make more than one bond to a metal ion, thereby augmenting the stability of the ion complex. They are used in numerous technical and industrial applications such as pulp & paper, chemical processing and consumer products among others. Certain chelating agents such as APCAs', sodium gluconates and organophosphonates are widely used in various household, industrial and water treatment applications. Key growth factors such as augmenting demand for chelating agents from cleaning & detergent industries and pulp & paper industry and the subsequent growth of these industries is expected drive the chelating agents market over the next few years. In addition, growing demand for clean and fresh water on account of stringent government policies is also expected to boost the demand for chelating agents in water treatment chemicals sector. Increasing concerns due to environmental hazards caused by the exposure of non-biodegradable chelating agents such as EDTA is expected to hamper the growth of the market. This in turn is opening new opportunities for companies across the globe to increase production of biodegradable chelating agents as they represent a safer alternative in comparison to the widely used non-biodegradable organic compounds. Chelating agents such as gluconates are experiencing significant growth in demand owing to its biodegradability. APCA were the majorly consumed chelating agents in the industry in 2012 and accounted for over 39% of the market share. APCAs' such as EDTA, DTPA and NTA are used in a wide range of applications such as water treatment, pulp & paper, agriculture, and household & industrial cleaning among others. Owing to its anthropogenic characteristic, EDTA has been significantly consumed within the industrial & household applications. However, on account of rising preference towards safer and better performing chelating agents, demand for organophosphonates and sodium gluconates has been on the rise, and is expected to follow a similar trend over the next few years. Demand for chelating agents was the highest from pulp & paper industry and the market was valued at USD 1,218.9 million in 2012. The industry has been witnessing exponential growth which in turn is driving the market, where chelating agents are extensively used in reducing costs and enhancing product quality in pulp & paper operations. Household & industrial cleaning was the second application segment of the market where chelating agents such as APCAs' and gluconates were significantly consumed as detergents and cleaning products. In addition, these products have been used as alternatives to phosphates in detergent formulation. However, the agrochemicals segment is expected to witness the fastest growth with bio-chemicals becoming increasingly popular as pro-environmental solutions. Scope Product Segment Analysis - APCA - Sodium gluconate - Organophosphonate - Others (Glucoheptonates, citric acid, etc.) Application Analysis - Pulp & paper - Household & industrial cleaning - Agrochemicals - Water treatment - Chemical processing - Consumer products - Others (Polymerization, metal working, nuclear, etc.) Key Topics Covered: - Preface - Executive Summary - Chelating Agents - Industry Analysis - Global Chelating Agents Market - Product Segment Analysis - Global Chelating Agents Market - Application Analysis - Global Chelating Agents Market - Regional Analysis - Company profiles - AkzoNobel N.V. - Archer Daniels Midland Company (ADM) - BASF SE - Cargill Incorporated - EMD Millipore - Kemira Oyj - Lanxess AG - Sigma-Aldrich Corporation - Tate & Lyle PLC - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/bq...ing_agents
Sigma-Aldrich Launches New Brand Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 6:20PM CDT
Sigma-Aldrich Corporation announced that its Cerilliant brand has launched four new Certified Spiking Solutions.
Cerilliant Introduces New Certified Snap-N-Spike® Solutions of Corticosteroids
PR Newswire - Wed Apr 16, 12:37PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that the Cerilliant® brand within its Applied Diagnostics and Testing Business Unit introduced four new Certified Spiking Solutions® of the corticosteroids pregnenolone, 17alpha-hydroxypregnenolone, cortisone, and 11-deoxycorticosterone at concentrations of 100 ug/mL in methanol.
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
Sigma-Aldrich Announces Q1 2014 Earnings Conference Call
PR Newswire - Fri Apr 04, 4:55PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, will hold its quarterly conference call to discuss first quarter 2014 financial results on Thursday, April 24, 2014, at 11:00 AM Eastern Time.
Global miRNA Market Outlook to 2018 Report Provides an In-Depth Analysis of the Various Aspects of R&D within the miRNA Industry
M2 - Tue Mar 18, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8jfvz6/global_mirna) has announced the addition of the "Global miRNA Market Outlook to 2018" report to their offering. The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA. Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another applications are in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression. After an exhaustive study of the industry, the authors have laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential. Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years. Companies Mentioned: - Agilent Technologies Inc. - GeneCopoeia - InteRNA Technologies B.V. - Life Technologies Corporation - miRagen Therapeutics - Mirna Therapeutics, Inc. - Qiagen - Regulus Therapeutics - Rosetta Genomics, Ltd. - Santaris Pharma A/S - Sigma-Aldrich Corporation - System Biosciences - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/8j...obal_mirna About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sigma-Aldrich Corporation Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Fri Mar 14, 9:31AM CDT
Levi & Korsinsky, LLP is investigating Sigma-Aldrich Corporation (NasdaqGS: SIAL) in connection with possible claims of breaches of fiduciary duty by certain of the members of the board of directors of the Company.
Sigma-Aldrich Earnings In Retrospect: Up 2.2% in the Last 18 Days (SIAL)
Comtex SmarTrend(R) - Mon May 12, 11:19AM CDT
18 days ago, on April 24th, 2014, Sigma-Aldrich (NASDAQ:SIAL) reported its earnings. Analysts, on average, expected earnings of $1.03 per share on sales of $690.0 million. Sigma-Aldrich actually reported earnings of $1.06 per share on sales of $689.0 million, beating EPS estimates by $0.03 and missing revenue estimates by $1.0 million. Since the company's report, shares of Sigma-Aldrich have risen from $94.76 to $96.84, representing a gain of 2.2% in the past 18 days.
Global Transfection Technology (Reagent-based method, Instrument-based method and Virus-based method) Market - Forecast to 2019
M2 - Fri May 09, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h75tdm/transfection) has announced the addition of the "Transfection Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Transfection is a process that involves production of genetically modified cells with the delivery of foreign nucleic acid (DNA or RNA) into the cell. There are two types of transfection technologies that include stable and transient. While stable transfection is permanent and the genes are continually expressed even after the host cell replicates, transient transfected genes are expressed for a limited period of time and are not integrated into the host genome. Increasing prevalence of cancer and growing obese population drives the global transfection technology market. In addition, initiatives taken by various government organizations also further accentuates the growth of this market. Transfection technologymarket is segmented mainly by types of method and application. The method segment of the market is classified as reagent-based method, instrument-based method and virus-based method. The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, cationic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Reagent based transfection technology market is experiencing significant growth owing to cost effectiveness and less complicated methods involved during transfection. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection.Instrument-based methods are less time consuming and accurate;these advantages drive the growth of this segment. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Transfection Technology Market, by Methods Chapter 5 Global Transfection Technology Market, By Application Chapter 6 Global Transfection Technology Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Bio-Rad Laboratories, Inc. - Harvard Bioscience, Inc. - Life Technologies Corporation - Lonza Group Ltd. - Merck KGaA - Mirus Bio LLC - Polyplus-transfection S.A. - Promega Corporation - QIAGEN - Roche Holding AG - Sigma-Aldrich Corporation - SignaGen Laboratories - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/h7...ansfection
Global Protein Expression Market, 2018: Products, Application & Expression Systems Opportunities
M2 - Wed May 07, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/62kkkn/protein) has announced the addition of the "Global Protein Expression Market, 2018: Products, Application & Expression Systems Opportunities " report to their offering. The report provides a granular understanding of the global protein expression market. It segments the global market by expression systems, products, applications, and end users. Insect, mammalian, prokaryotic, yeast, and others are the expression system segments of the market. The prokaryotic expression system segment commanded the largest share of the global market in 2013. The mammalian cell expression system segment is poised to grow at the highest CAGR between 2013 and 2018, owing to the increase in demand of therapeutic proteins with appropriate post-translational modifications. The product segments of the global market included in this report are competent cells, expression vectors, instruments, reagents, and services. The reagents segment commanded the largest share of the global market, while the services segment is poised to grow at the highest CAGR between 2013 and 2018 on account of the rising trend of services that provide custom optimization of protein expression for emerging research labs and companies who lack resources and expertise. The applications segment of the global protein expression market comprises of industrial proteins, research applications, and therapeutic proteins. Of these, the therapeutic proteins segment commanded the largest share of the global market in 2013. It is also poised to grow at the highest CAGR between 2013 and 2018, owing to the versatile advantages of therapeutic proteins over small molecule drugs to alleviate diseases. The end-user segments of the global protein expression market included in this report are academic research, contract research organizations, pharmaceutical and biotechnological companies, and others. The pharmaceutical and biotechnological companies segment commanded the largest share of the global market, while the contract research organizations segment is poised to grow at the highest CAGR between 2013 and 2018 due to the growing trends of outsourcing by pharmaceutical and biotechnological companies. Scope Products - Expression Vector - Service - Reagent Application - Industrial - Therapeutic Expression Systems - Mammalian - Prokaryotic - Baculovirus - Yeast End User - Pharmaceutical - Biotechnology - CRO Companies Mentioned - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Life Technologies Corporation - Merck Millipore - New England Biolabs, Inc. - Promega Corporation - Qiagen - Sigma-Aldrich Corporation - Takara Bio, Inc. - Thermo Fischer Scientific Inc. For more information visit http://www.researchandmarkets.com/research/62kkkn/protein
SAFC's Pharmorphix® Technologies and BioTools Align to Provide End-to-End Chiral Technology Tools and Services
PR Newswire - Wed May 07, 6:00AM CDT
Sigma-Aldrich® Corporation's (NASDAQ: SIAL) custom manufacturing and services business unit, SAFC Commercial (www.sigma-aldrich.com/safc), has entered into a collaborative technology agreement with BioTools Inc. (www.btools.com). The partnership aligns BioTools, a Jupiter, Fla.-based manufacturer of advanced chiroptical spectroscopic instruments, with SAFC's leading solid-state research and development business, Pharmorphix®. The combined offer provides customers direct access to the most comprehensive range of chiral structural determination tools and separation services in the market, potentially accelerating timelines to market for chiral-based drugs.
Sigma-Aldrich Corporation Declares Quarterly Dividend
PR Newswire - Tue May 06, 4:00PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company (the "Company"
, announces a quarterly cash dividend of $0.23 per common share. The dividend was approved by the Company's Board of Directors on May 6, 2014 and is payable on June 13, 2014 to shareholders of record at the close of business on May 30, 2014. Sigma-Aldrich Launches High-Fidelity CRISPRs to Enable Precise Gene Editing for Academic and Industrial Applications
PR Newswire - Tue May 06, 6:00AM CDT
Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the availability of high-fidelity Sigma® CRISPR paired nickases, a novel patent-pending gene editing tool that can be easily and inexpensively employed in academic, agricultural, pharmaceutical, human health and other applications. The high-fidelity CRISPR technology has been designed to reduce unintended off-target gene modifications, providing the research community with a robust, reliable and precise tool to interrogate and modify plant, animal, and human biology.
Reported and Upcoming Financial Results, and Dividends - Analyst Notes on Cloud Peak Energy, Rockwood, Denbury, Sigma-Aldrich and Alliance Resource Partners
PR Newswire - Fri May 02, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cloud Peak Energy Inc. (NYSE: CLD), Rockwood Holdings, Inc. (NYSE: ROC), Denbury Resources Inc. (NYSE: DNR), Sigma-Aldrich Corporation (NASDAQ: SIAL) and Alliance Resource Partners, L.P. (NASDAQ: ARLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1950-100free.
Sigma-Aldrich Corporation Announces Webcasts Of Annual Shareholders Meeting And Participation At Investor Conferences
PR Newswire - Thu May 01, 3:05PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), will hold its 2014 Annual Shareholders Meeting on Tuesday, May 6, 2014 at 11:00 AM Central Time at the Sigma-Aldrich Corporation Life Science and Technology Center located at 2909 Laclede Avenue, St. Louis, MO. Presenters will include: President and CEO, Rakesh Sachdev; and Executive Vice-President and CFO, Jan Bertsch. The Annual Meeting Rules of Conduct are available at http://investor.sigmaaldrich.com/ under "Corporate Governance."
Sigma-Aldrich® Named to CR Magazine's 100 Best Corporate Citizens List
PR Newswire - Wed Apr 30, 6:00AM CDT
Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named by Corporate Responsibility (CR) Magazine to its list of the 100 Best Corporate Citizens, which ranks public companies based on outstanding corporate responsibility performance in 2013. Sigma-Aldrich ranked 28 on the list in its third appearance.
Global Cell Analysis Market 2014-2019: Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR) & Application (Cell ID, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell)
M2 - Mon Apr 28, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8bcf6h/cell_analysis) has announced the addition of the "Global Cell Analysis Market 2014-2019: Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables & Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis)" report to their offering. In the recent years, the adoption of Cell Analysis for Cell identification, single cell analysis, cell proliferation, cell signaling, cell viability, cell signaling/transduction pathway, cell counting and quality control, cell structure study, and cell interaction, has increased. The market is broadly classified based on products, applications, end users, and geographies. The products market is further divided into instruments and consumables. The instruments market is sub-divided into cell counting instruments, microscopy, flow cytometry, high content screening, spectrophotometery, microfluidics, qRT-PCR, and cell microarrays. The consumables market is further segmented into reagents and assay kits, microplates, and other consumables. The applications market includes cell identification, cell interaction, cell viability, cell proliferation, cell structure studies, cell signaling pathway/signal transduction, cell counting and quality control, target identification, and validation and single cell analysis. Cell identification has its application in the identification of blood cells on the basis of their size and other morphological features such as presence or absence of nucleus in the cell and shape of nucleus. Cell identification is also used in tumor cell identification with the help of Raman spectroscopy and microfluidics. In target identification, HCS is used to identify novel targets through the screening of cellular pathways. HCS can also provide more accurate information about drug toxicity and mode of actions, which helps in further decision making and in driving the progress of drug discovery. Cell signalling pathways are used for the analysis of signalling pathways in drug discovery and therapeutic development, to differentiate drug resistant patterns in cancerous cells. The major factors driving the growth of the market are the rising incidence of cancer, corporate and government funding for cell-based research activities, rising incidence of chronic and infectious diseases, introduction of enhanced informatics solutions and improvements in image analysis products, and growing healthcare and medical spending. Moreover, the adoption of cell analysis for cell identification and cell signaling pathways/signal transduction pathways is the key growth opportunity in this market. Scope Instruments - Flow Cytometer - Microscope - Microfluidics - QPCR Consumables Application - Cell Identification - Cell Viability - Cell Proliferation - Cytology - Signal Transduction - Single Cell Analysis The report provides insights on the following pointers: - Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the cell analysis market. The report analyzes the cell analysis market by application across geographies. - Product Development/Innovation: Detailed insights on research and development activities and new product launches in the cell analysis market. - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the cell analysis market by product across geographies. - Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market. - Competitive Assessment: In-depth assessment of strategies, products and services, and distribution networks in the cell analysis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Analysis Market, By Product Type 5 Products Market 6 Global Cell Analysis Market, By End Users 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - Agilent Technologies, Inc. - Beckton, Dickinson and Company - Danaher Corporation - GE Healthcare - Merck KGAA - Olympus Corpopration - Perkinelmer, Inc. - Promega Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8b...l_analysis
Sigma-Aldrich Q1 Earnings Top, Backs View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 11:49AM CDT
Sigma-Aldrich's (SIAL) first-quarter earnings topped the Zacks Consensus Estimate but sales miss.
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q1 2014 Results With Sales Of $689 Million And Adjusted Diluted EPS Of $1.06. Reaffirms Full-Year 2014 Adjusted Diluted EPS Guidance Of $4.30 To $4.40.
PR Newswire - Thu Apr 24, 7:00AM CDT
HIGHLIGHTS:
Earnings Release Schedule -- Research on Coca-Cola Enterprises, Alexion Pharma, DuPont Fabros Technology, and Sigma-Aldrich
PR Newswire - Wed Apr 23, 10:03AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Coca-Cola Enterprises Inc. (NYSE: CCE), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), DuPont Fabros Technology Inc. (NYSE: DFT) and Sigma-Aldrich Corp. (NASDAQ: SIAL). Full earnings notes on CCE, ALXN, DFT and SIAL can be downloaded upon signing up at:
Chelating Agents Market Report 2013-2019: APCA, Sodium Gluconate, Organophosphates and Others
M2 - Tue Apr 22, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bq6tmq/chelating_agents) has announced the addition of the "Chelating Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Chelating agents are organic molecules, which have the ability to make more than one bond to a metal ion, thereby augmenting the stability of the ion complex. They are used in numerous technical and industrial applications such as pulp & paper, chemical processing and consumer products among others. Certain chelating agents such as APCAs', sodium gluconates and organophosphonates are widely used in various household, industrial and water treatment applications. Key growth factors such as augmenting demand for chelating agents from cleaning & detergent industries and pulp & paper industry and the subsequent growth of these industries is expected drive the chelating agents market over the next few years. In addition, growing demand for clean and fresh water on account of stringent government policies is also expected to boost the demand for chelating agents in water treatment chemicals sector. Increasing concerns due to environmental hazards caused by the exposure of non-biodegradable chelating agents such as EDTA is expected to hamper the growth of the market. This in turn is opening new opportunities for companies across the globe to increase production of biodegradable chelating agents as they represent a safer alternative in comparison to the widely used non-biodegradable organic compounds. Chelating agents such as gluconates are experiencing significant growth in demand owing to its biodegradability. APCA were the majorly consumed chelating agents in the industry in 2012 and accounted for over 39% of the market share. APCAs' such as EDTA, DTPA and NTA are used in a wide range of applications such as water treatment, pulp & paper, agriculture, and household & industrial cleaning among others. Owing to its anthropogenic characteristic, EDTA has been significantly consumed within the industrial & household applications. However, on account of rising preference towards safer and better performing chelating agents, demand for organophosphonates and sodium gluconates has been on the rise, and is expected to follow a similar trend over the next few years. Demand for chelating agents was the highest from pulp & paper industry and the market was valued at USD 1,218.9 million in 2012. The industry has been witnessing exponential growth which in turn is driving the market, where chelating agents are extensively used in reducing costs and enhancing product quality in pulp & paper operations. Household & industrial cleaning was the second application segment of the market where chelating agents such as APCAs' and gluconates were significantly consumed as detergents and cleaning products. In addition, these products have been used as alternatives to phosphates in detergent formulation. However, the agrochemicals segment is expected to witness the fastest growth with bio-chemicals becoming increasingly popular as pro-environmental solutions. Scope Product Segment Analysis - APCA - Sodium gluconate - Organophosphonate - Others (Glucoheptonates, citric acid, etc.) Application Analysis - Pulp & paper - Household & industrial cleaning - Agrochemicals - Water treatment - Chemical processing - Consumer products - Others (Polymerization, metal working, nuclear, etc.) Key Topics Covered: - Preface - Executive Summary - Chelating Agents - Industry Analysis - Global Chelating Agents Market - Product Segment Analysis - Global Chelating Agents Market - Application Analysis - Global Chelating Agents Market - Regional Analysis - Company profiles - AkzoNobel N.V. - Archer Daniels Midland Company (ADM) - BASF SE - Cargill Incorporated - EMD Millipore - Kemira Oyj - Lanxess AG - Sigma-Aldrich Corporation - Tate & Lyle PLC - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/bq...ing_agents
Sigma-Aldrich Launches New Brand Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 6:20PM CDT
Sigma-Aldrich Corporation announced that its Cerilliant brand has launched four new Certified Spiking Solutions.
Cerilliant Introduces New Certified Snap-N-Spike® Solutions of Corticosteroids
PR Newswire - Wed Apr 16, 12:37PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that the Cerilliant® brand within its Applied Diagnostics and Testing Business Unit introduced four new Certified Spiking Solutions® of the corticosteroids pregnenolone, 17alpha-hydroxypregnenolone, cortisone, and 11-deoxycorticosterone at concentrations of 100 ug/mL in methanol.
Global Proteomics Market (Technology, Instruments, Reagents & Services) - Global Forecast to 2018
M2 - Tue Apr 08, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2hnkrt/proteomics_market) has announced the addition of the "Proteomics Market by Technology, Instruments, Reagents & Services - Global Forecast to 2018" report to their offering. The global market was valued at an estimated $10,223.3 million in 2013. The growth of this market is mainly fuelled by the increasing need for personalized medicine, growth in pharmaceutical and biotechnology research and development (R&D) expenditure, technological advancements, and availability of government and private funding for proteomics projects.The overall market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. This report discusses the key market drivers, restraints, and opportunities in the global proteomics market and its sub-markets. Based on reagents type, the market is segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation kits. Furthermore, the services market is sub-divided into analytical laboratory services, and data analysis and maintenance. Analytical laboratory services are further segmented into three types, namely, protein identification, protein separation, and protein sequencing. Data analysis and maintenance is further divided into bioinformatics databases and bioinformatics tools. North America accounted for the largest share of the global market in 2013, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The growth in the Asian market is attributed to the shift of focus of the proteomics research-related industries towards Asia and the increase in both public and private funding to boost proteomic research in the region. Scope of the Report Proteomics Instrumentation Technologies - Protein Microarray - - Biochips - - Microarray instruments - Spectroscopy - - Mass spectrometry - - NMR spectrometry - - Circular dichroism (CD) spectroscopy - X-ray Crystallography - Chromatography - - HPLC Systems - - Affinity chromatography - - Ion chromatography - Supercritical Fluid Chromatography - Electrophoresis - - Gel electrophoresis - - Capillary electrophoresis - Surface Plasmon Resonance System (SPR System) - Protein Fractionation System Proteomics Reagents - Microarray - Spectroscopy - X-ray Crystallography - Chromatography - Electrophoresis - Immunoassay - Microsphere - Protein Fractionation Kits Proteomics Services - Analytical Laboratory Services - Protein Identification - Protein Separation - Protein Sequencing - Data Analysis and Maintenance - Bioinformatics Databases - Bioinformatics Tools - Global Proteomics Market, by Application - Drug Discovery - Diagnosis Key Topics Covered: - Introduction - Executive Summary - Premium Insights - Market Overview - Proteomics Instrumentation Technology - Proteomics Reagents Market - Proteomics Services Market - Proteomics Applications Market - Geographic Analysis - Competitive Landscape - Company Profiles - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Luminex Corporation - Danaher Corporation - Ge Healthcare - Waters Corporation - Affymetrix Inc. - Perkinelmer, Inc. - Sigma-Aldrich Corp Visit http://www.researchandmarkets.com/research/2h...ics_market
Sigma-Aldrich Announces Q1 2014 Earnings Conference Call
PR Newswire - Fri Apr 04, 4:55PM CDT
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, will hold its quarterly conference call to discuss first quarter 2014 financial results on Thursday, April 24, 2014, at 11:00 AM Eastern Time.
Global miRNA Market Outlook to 2018 Report Provides an In-Depth Analysis of the Various Aspects of R&D within the miRNA Industry
M2 - Tue Mar 18, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8jfvz6/global_mirna) has announced the addition of the "Global miRNA Market Outlook to 2018" report to their offering. The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA. Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another applications are in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression. After an exhaustive study of the industry, the authors have laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential. Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years. Companies Mentioned: - Agilent Technologies Inc. - GeneCopoeia - InteRNA Technologies B.V. - Life Technologies Corporation - miRagen Therapeutics - Mirna Therapeutics, Inc. - Qiagen - Regulus Therapeutics - Rosetta Genomics, Ltd. - Santaris Pharma A/S - Sigma-Aldrich Corporation - System Biosciences - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/8j...obal_mirna About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sigma-Aldrich Corporation Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Fri Mar 14, 9:31AM CDT
Levi & Korsinsky, LLP is investigating Sigma-Aldrich Corporation (NasdaqGS: SIAL) in connection with possible claims of breaches of fiduciary duty by certain of the members of the board of directors of the Company.
